News

TCTMD13h
Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli
As in the SMART trial, early hemodynamic differences have yet to result in a clinical impact—but it may just be a matter of ...
The Cardiology Advisor5d
FDA Approves SAPIEN 3 Platform for Asymptomatic Severe Aortic Stenosis
The FDA has approved the SAPIEN 3 platform, a TAVR therapy, for patients with severe aortic stenosis without symptoms.
European Medical Journal8d
ASCoP Registry: New Data Support Staging TAVI and PCI in Severe Aortic Stenosis
Find out why staging TAVI and PCI lowers risk in complex heart cases - read the latest insights from the ASCoP registry.
Science Daily10d
MRI breakthrough could revolutionize diagnosis of common heart problem aortic stenosis
Researchers have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before. Aortic stenosis is a progressive and potentially fatal condition ...
The Star14d
Zii Jia and others can opt out of RTG if they want to
The Road to Gold (RTG) chairman Hannah Yeoh has clarified that the 16 athletes chosen are not obligated to join the national elite sports programme, which is aimed to secure Malaysia’s first ...
Hosted on MSN14d
FDA Approves SAPIEN 3 Platform for Asymptomatic Severe Aortic Stenosis
In the EARLY TAVR trial, which informed the approval, patients with asymptomatic severe aortic stenosis were randomly assigned to either TAVR or watchful waiting. During a median follow-up of 3.8 ...
Daily Journal15d
FDA Approves SAPIEN 3 Platform for Asymptomatic Severe Aortic Stenosis
MONDAY, May 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved the SAPIEN 3 platform, a transcatheter aortic valve replacement (TAVR) therapy, for patients with severe ...